Cortexyme Stock Predictions

Healthcare > Biotechnology

Buy CRTX

*Your capital is at risk

$2.20

+0 (+0%)

At Close: Nov 04, 2022

Currently predicting for Thu, 6 Aug 2026

CRTX Live board

Community Bull/Bear

Target Next close

Join the CRTX prediction battle

Create a free account to see the full board, submit your call, compare with other predictors, and build a public record.

Create free account Log in

CRTX Prediction Chart

Unlock the prediction chart

Registered users can inspect target prices, community averages, and how calls develop across recent sessions.

Create free account Log in

Forecast Desk

3-Month Forecasts For CRTX

Forecasts map a 66-session price path from approved predictors. Log in or create a free account to view forecasts and request one for this ticker.

Create free account Log in to view forecasts

CRTX Predictions History

Predictor	Target Session	Target Price	Accuracy
Community predictor	Next session	USD target	Record locked
Ranked predictor	Previous session	Bullish/Bearish	Score locked

See the prediction record

Create free account Log in

Forecast Desk

Request A 3-Month Forecast

Price path
Approved predictor
3-month horizon

Create Free Account Log In To View Forecasts

ABOUT CORTEXYME INC.

Cortexyme, Inc., a clinical stage biopharmaceutical company, focuses on developing therapeutics for Alzheimer's and other degenerative diseases. Its lead drug candidate is atuzaginstat (COR388), an orally administered brain-penetrating small molecule gingipain inhibitor, which is in Phase II/III clinical trial for use in patients with mild to moderate Alzheimer's disease, as well as for the treatment of oral squamous cell carcinoma, periodontitis...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
N NXDR $2.27	7.93%	Aug 03
MC $67.08	3.53%	Jul 31
FCX $62.63	10.79%	Jul 31
ARW $212.85	6.58%	Jul 30
BIIB $202.19	2.20%	Jul 24

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by